Suppr超能文献

2021 年德国对严重急性呼吸综合征冠状病毒 2 进行分子和基因组监测以推进精准疫苗学

Advancing Precision Vaccinology by Molecular and Genomic Surveillance of Severe Acute Respiratory Syndrome Coronavirus 2 in Germany, 2021.

机构信息

Influenza and Other Respiratory Viruses (FG17), Robert Koch Institute, Berlin, Germany.

Methodology and Research Infrastructure, Bioinformatics and Systems Biology (MF1), Robert Koch Institute, Berlin, Germany.

出版信息

Clin Infect Dis. 2022 Aug 15;75(Suppl 1):S110-S120. doi: 10.1093/cid/ciac399.

Abstract

BACKGROUND

Comprehensive pathogen genomic surveillance represents a powerful tool to complement and advance precision vaccinology. The emergence of the Alpha variant in December 2020 and the resulting efforts to track the spread of this and other severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern led to an expansion of genomic sequencing activities in Germany.

METHODS

At Robert Koch Institute (RKI), the German National Institute of Public Health, we established the Integrated Molecular Surveillance for SARS-CoV-2 (IMS-SC2) network to perform SARS-CoV-2 genomic surveillance at the national scale, SARS-CoV-2-positive samples from laboratories distributed across Germany regularly undergo whole-genome sequencing at RKI.

RESULTS

We report analyses of 3623 SARS-CoV-2 genomes collected between December 2020 and December 2021, of which 3282 were randomly sampled. All variants of concern were identified in the sequenced sample set, at ratios equivalent to those in the 100-fold larger German GISAID sequence dataset from the same time period. Phylogenetic analysis confirmed variant assignments. Multiple mutations of concern emerged during the observation period. To model vaccine effectiveness in vitro, we employed authentic-virus neutralization assays, confirming that both the Beta and Zeta variants are capable of immune evasion. The IMS-SC2 sequence dataset facilitated an estimate of the SARS-CoV-2 incidence based on genetic evolution rates. Together with modeled vaccine efficacies, Delta-specific incidence estimation indicated that the German vaccination campaign contributed substantially to a deceleration of the nascent German Delta wave.

CONCLUSIONS

SARS-CoV-2 molecular and genomic surveillance may inform public health policies including vaccination strategies and enable a proactive approach to controlling coronavirus disease 2019 spread as the virus evolves.

摘要

背景

综合病原体基因组监测代表了一种强大的工具,可以补充和推进精准疫苗学。2020 年 12 月阿尔法变异株的出现,以及随后追踪这种变异株和其他严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)关切变异株传播的努力,导致德国扩大了基因组测序活动。

方法

在罗伯特·科赫研究所(RKI),即德国国家公共卫生研究所,我们建立了综合 SARS-CoV-2 分子监测(IMS-SC2)网络,在国家范围内进行 SARS-CoV-2 基因组监测,德国各地实验室的 SARS-CoV-2 阳性样本定期在 RKI 进行全基因组测序。

结果

我们报告了 2020 年 12 月至 2021 年 12 月期间收集的 3623 个 SARS-CoV-2 基因组的分析结果,其中 3282 个是随机抽样的。在测序样本集中发现了所有关切变异株,其比例与同期德国 GISAID 序列数据集(100 倍大)中的比例相当。系统发育分析证实了变异株的分配。在观察期间出现了多个关切突变。为了在体外模拟疫苗效力,我们采用了真实病毒中和测定,证实了 Beta 和 Zeta 变异株都具有免疫逃逸能力。IMS-SC2 序列数据集有助于根据遗传进化率估计 SARS-CoV-2 的发病率。结合模型化的疫苗效力,德尔塔特定发病率估计表明,德国的疫苗接种运动对减缓德国德尔塔波的出现起到了重要作用。

结论

SARS-CoV-2 分子和基因组监测可以为包括疫苗接种策略在内的公共卫生政策提供信息,并能够在病毒进化时采取积极主动的方法控制 2019 年冠状病毒病的传播。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3e5/9376278/3a56f9d17a8c/ciac399f1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验